Sangamithra Ravishankaran, Shalu Thomas, Aswin Asokan, Johnson Amala Justin Nalapatty Anthonysamy, Manu Thomas Mathai, Vaishali Verma, Raghavendra Kamaraju, Alex Eapen
{"title":"Emerging Resistance in Anopheles stephensi Larvae to the Larvicide Temephos in Chennai, India.","authors":"Sangamithra Ravishankaran, Shalu Thomas, Aswin Asokan, Johnson Amala Justin Nalapatty Anthonysamy, Manu Thomas Mathai, Vaishali Verma, Raghavendra Kamaraju, Alex Eapen","doi":"10.4269/ajtmh.25-0232","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to evaluate the susceptibility of immature Anopheles stephensi to temephos formulation, a primary antilarval intervention currently in operational use. The assessment was conducted against both the WHO-recommended discriminatory dosage with temephos (0.25 parts per million [ppm]) and the operational field dosage with temephos 50% emulsifiable concentrate (EC; 1 ppm). F1 generation immature An. stephensi from two areas of Chennai, India was used for the study. The larvae (F1) from both areas were fully susceptible to the WHO discriminatory dosage. Larval susceptibility tests with temephos 50% EC observed 100% mortality in Thiruvanmiyur strains at 40 ppm (lethal concentration at which 99% of the exposed larvae were dead [LC99]: 37.47-45.06 ppm). However, Adyar strains exhibited 98.7% mortality at 50 ppm (LC99: 59.79 ppm). Anopheles stephensi larvae from both areas showed resistance to operational field dosage (1 ppm). Prolonged insecticide exposure precipitates resistance, highlighting the need for routine larvicide efficacy monitoring to support disease elimination efforts.</p>","PeriodicalId":7752,"journal":{"name":"American Journal of Tropical Medicine and Hygiene","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4269/ajtmh.25-0232","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to evaluate the susceptibility of immature Anopheles stephensi to temephos formulation, a primary antilarval intervention currently in operational use. The assessment was conducted against both the WHO-recommended discriminatory dosage with temephos (0.25 parts per million [ppm]) and the operational field dosage with temephos 50% emulsifiable concentrate (EC; 1 ppm). F1 generation immature An. stephensi from two areas of Chennai, India was used for the study. The larvae (F1) from both areas were fully susceptible to the WHO discriminatory dosage. Larval susceptibility tests with temephos 50% EC observed 100% mortality in Thiruvanmiyur strains at 40 ppm (lethal concentration at which 99% of the exposed larvae were dead [LC99]: 37.47-45.06 ppm). However, Adyar strains exhibited 98.7% mortality at 50 ppm (LC99: 59.79 ppm). Anopheles stephensi larvae from both areas showed resistance to operational field dosage (1 ppm). Prolonged insecticide exposure precipitates resistance, highlighting the need for routine larvicide efficacy monitoring to support disease elimination efforts.
期刊介绍:
The American Journal of Tropical Medicine and Hygiene, established in 1921, is published monthly by the American Society of Tropical Medicine and Hygiene. It is among the top-ranked tropical medicine journals in the world publishing original scientific articles and the latest science covering new research with an emphasis on population, clinical and laboratory science and the application of technology in the fields of tropical medicine, parasitology, immunology, infectious diseases, epidemiology, basic and molecular biology, virology and international medicine.
The Journal publishes unsolicited peer-reviewed manuscripts, review articles, short reports, images in Clinical Tropical Medicine, case studies, reports on the efficacy of new drugs and methods of treatment, prevention and control methodologies,new testing methods and equipment, book reports and Letters to the Editor. Topics range from applied epidemiology in such relevant areas as AIDS to the molecular biology of vaccine development.
The Journal is of interest to epidemiologists, parasitologists, virologists, clinicians, entomologists and public health officials who are concerned with health issues of the tropics, developing nations and emerging infectious diseases. Major granting institutions including philanthropic and governmental institutions active in the public health field, and medical and scientific libraries throughout the world purchase the Journal.
Two or more supplements to the Journal on topics of special interest are published annually. These supplements represent comprehensive and multidisciplinary discussions of issues of concern to tropical disease specialists and health issues of developing countries